1. Home
  2. GNFT vs EARN Comparison

GNFT vs EARN Comparison

Compare GNFT & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • EARN
  • Stock Information
  • Founded
  • GNFT 1999
  • EARN 2012
  • Country
  • GNFT France
  • EARN United States
  • Employees
  • GNFT N/A
  • EARN N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • EARN Real Estate Investment Trusts
  • Sector
  • GNFT Health Care
  • EARN Real Estate
  • Exchange
  • GNFT Nasdaq
  • EARN Nasdaq
  • Market Cap
  • GNFT 190.6M
  • EARN 187.6M
  • IPO Year
  • GNFT 2019
  • EARN 2013
  • Fundamental
  • Price
  • GNFT $3.58
  • EARN $6.35
  • Analyst Decision
  • GNFT Strong Buy
  • EARN Hold
  • Analyst Count
  • GNFT 1
  • EARN 1
  • Target Price
  • GNFT $13.00
  • EARN N/A
  • AVG Volume (30 Days)
  • GNFT 6.8K
  • EARN 547.3K
  • Earning Date
  • GNFT 09-19-2024
  • EARN 03-05-2025
  • Dividend Yield
  • GNFT N/A
  • EARN 14.93%
  • EPS Growth
  • GNFT N/A
  • EARN 277.67
  • EPS
  • GNFT 0.47
  • EARN 1.02
  • Revenue
  • GNFT $86,225,222.00
  • EARN N/A
  • Revenue This Year
  • GNFT $155.44
  • EARN N/A
  • Revenue Next Year
  • GNFT N/A
  • EARN $89.08
  • P/E Ratio
  • GNFT $7.34
  • EARN $6.28
  • Revenue Growth
  • GNFT 175.45
  • EARN N/A
  • 52 Week Low
  • GNFT $3.31
  • EARN $5.54
  • 52 Week High
  • GNFT $6.42
  • EARN $7.26
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 33.20
  • EARN 36.53
  • Support Level
  • GNFT $3.58
  • EARN $6.47
  • Resistance Level
  • GNFT $3.90
  • EARN $6.68
  • Average True Range (ATR)
  • GNFT 0.13
  • EARN 0.14
  • MACD
  • GNFT 0.03
  • EARN -0.03
  • Stochastic Oscillator
  • GNFT 0.00
  • EARN 3.77

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on strong risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times of stress. It also leverages Ellington's proprietary technology, analytics and risk management systems to enhance underwriting and investment selection and to guide ongoing portfolio monitoring and surveillance.

Share on Social Networks: